GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CurveBeam AI Ltd (ASX:CVB) » Definitions » Interest Expense

CurveBeam AI (ASX:CVB) Interest Expense : A$-1.33 Mil (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is CurveBeam AI Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. CurveBeam AI's interest expense for the six months ended in Dec. 2023 was A$ -1.33 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was A$-1.33 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. CurveBeam AI's Operating Income for the six months ended in Dec. 2023 was A$ -13.59 Mil. CurveBeam AI's Interest Expense for the six months ended in Dec. 2023 was A$ -1.33 Mil. CurveBeam AI did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


CurveBeam AI Interest Expense Historical Data

The historical data trend for CurveBeam AI's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CurveBeam AI Interest Expense Chart

CurveBeam AI Annual Data
Trend Jun21 Jun22 Jun23
Interest Expense
-0.56 -0.12 -5.73

CurveBeam AI Semi-Annual Data
Jun21 Dec21 Jun22 Jun23 Dec23
Interest Expense - -0.35 0.22 - -1.33

CurveBeam AI Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-1.33 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CurveBeam AI  (ASX:CVB) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

CurveBeam AI's Interest Expense for the six months ended in Dec. 2023 was A$-1.33 Mil. Its Operating Income for the six months ended in Dec. 2023 was A$-13.59 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was A$13.51 Mil.

CurveBeam AI's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

CurveBeam AI did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


CurveBeam AI (ASX:CVB) Business Description

Traded in Other Exchanges
N/A
Address
10?16 Queen Street, Level 10, Melbourne, VIC, AUS, 3000
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the Company's CT devices to assist in the clinical assessment and management of musculoskeletal health conditions, with a focus on orthopedic and bone health issues. The Company is the first to market with natural bilateral weight-bearing and non-weight-bearing CT, point-of-care imaging equipment with targeted proprietary AI solutions.

CurveBeam AI (ASX:CVB) Headlines

No Headlines